HGM has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
HGM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
HGM Limited (formerly HOV Services) reported strong Q1 FY26 results with total revenue of ₹1,412.62 lakhs, up 135% year-on-year and 137% quarter-on-quarter, driven by AI-enabled healthcare services and a headcount increase to ~1,300 from ~600. Profit after tax surged 122% YoY to ₹172.86 lakhs, while EBITDA more than doubled to ₹289.38 lakhs. EPS rose to ₹1.37 (up 121% YoY). The board also approved the sale/transfer of its US wholly-owned subsidiary HOVS LLC and the incorporation of a new subsidiary in the Cayman Islands. Statutory auditors Lodha & Co LLP issued an unmodified review opinion, and the company remains debt-free.
Sharp revenue and profit growth, debt-free balance sheet, and focus on AI-driven healthcare services are positive signals for shareholders. Investors should monitor the proposed HOVS LLC divestment and the sharp decline in fair value of the Exela Technologies investment (from ₹216.73 lakhs to ₹55.29 lakhs) for any near-term impact.